Hey, there

Maryrose is a Group Senior Vice President and Client Relationship Lead in the Biopharma practice at GHMC. She leads a portfolio of accounts that include global HCP & consumer marketing, medical communications and public relations/corporate communications.​

For more than 20 years, Maryrose has worked for and with Fortune 100 companies across the healthcare spectrum spanning biopharma, health & wellness and payers. Maryrose brings deep expertise in the development of compelling narratives and engaging communication platforms & programs that influence stakeholders, build & protect reputations and further business goals. Maryrose also has a strong track record of building high performing teams and developing talent. ​

Prior to her time at GHMC, Maryrose led communications for Anthem’s (now Elevance Health) care delivery businesses, CareMore Health and Aspire Health, and telehealth offering – LiveHealth Online. She was also a member of the integrated marketing & communications team supporting Anthem’s transformation into a digital-first company, enabling AI and other technologies to anticipate and address evolving customer needs. ​

During her 7+ year tenure at Pfizer, Maryrose spearheaded communications for multiple marquee global brands such as Lyrica, Viagra, Chantix and Eliquis. From data milestones, patient recruitment and engagement, regulatory approvals to LOE and in support of large-scale disease awareness campaigns with national non-profit organizations, her work often broke the mold and contributed to meeting and/or exceeding business goals. ​

Maryrose started her career working with biopharma and consumer health companies and brings a passion for science and storytelling to her work. She earned her degree from Rutgers University in New Jersey and lives in New York with her husband and two sons.

Brandon joined GHMC in September 2021 and currently serves as a Vice President. Brandon has been on the agency side for 16 years, specifically specializing in pharmaceutical marketing for 13 years. His expertise is working with pre-launch brands in specific therapeutic areas, as well as leading the strategic realignment of post-launch brands.

Brandon is a believer in the art of collaboration and championing the key role it plays to uncover meaningful insights that will drive creative solutions for brands. Brandon has used this perspective in driving successful HCP and consumer launch efforts in the schizophrenia, diabetes, hemophilia, rheumatoid arthritis, and women’s health space across his career.

Brandon graduated from Temple University in Philadelphia, PA with a degree in their communications program with a specific focus in advertising and public relations.

Chris is an experienced healthcare communications consultant, with over a decade’s experience working on Global, European and UK communication and marketing programmes, with an expertise in digital innovation and insights having previously held the role Digital Insights Lead for two years prior.

Chris’ move to Managing Director of GHMC’s UK office followed his work leading the development of the team’s creative and evaluation framework, which ensures client strategies are supported by data and insights that not only help develop engaging programmes but can help prove that they make a difference.

Chris has worked across a number of disease areas but has a particular expertise in creating campaigns that made a difference to patients’ lives, having worked on digital strategy and patient engagement in cystic fibrosis, rare disease, oncology, diabetes and MS and has supported strategy, brand, and patient engagement for a number of pharma and medical device companies in the UK and Europe.

His expertise in digital programmes is underlined by his graduation from Google Squared, Google’s digital leadership and marketing course. He was recognized in the Industry as he was a speaker at Digital Shoreditch 2015 discussing the present and future impact of the Internet of Things and connectivity in health, and is currently on the PM Society digital interest group informing industry direction of digital thought-leadership and innovation.

Sebastian joined GHMC in July 2021 as a Director, with over a decade’s experience in healthcare communications.

Sebastian has worked across a breadth of pharmaceutical and patient-led communications campaigns and has embedded a new culture of creativity at GHMC. Seb has worked closely with the World Health Organization for the last 6 years developing communications strategies, global creative platforms, and social and digital media campaigns. He also works with Movember on their creative communications, HCP engagement, and medical communications for their work across prostate and testicular cancer, as well as men’s mental health initiatives.

Seb blends creative inspiration from outside Pharma and always looks to bring those learnings into the industry to develop more engaging and breakthrough communications campaigns. He has worked extensively in dermatology in the past in psoriasis, atopic dermatitis, and rosacea.

Seb has won several award-winning campaigns at PR Week Global Awards and Communique awards, which this year he has been invited to return as a judge for. Seb has developed content and social media programmes for Pfizer covering smoking cessation and driving behaviour change to drive cessation messaging in social communities. He has also been consulting with Teva Pharmaceuticals in creating new digital global content approvals processes and developing new global content platforms to serve local country operations.

Ross has over 20 years of experience in the healthcare industry, currently running the SONIC Story Lab, a division within GHMC focused on bringing Hollywood style-storytelling to healthcare.

Prior to joining GHMC, Ross was the co-founder of SONIC Health, an independent, strategy-focused healthcare agency. He served as the SVP of Innovation for WEGO Health, where he led product innovation efforts responsible for transforming the way the healthcare industry connects with patient influencers. He was a founding member of CureClick, a clinical trial recruitment and community building platform.

Ross is a digital health agency veteran, holding leadership roles in digital strategy, analytics, new business and account management at Ignite Health, Medical Broadcasting Company (now Digitas Health) and i-Frontier (now Razorfish Health).

Ross is a graduate of Haverford College, where he received a degree in English. He is also a screenwriter in his spare time.

Darryl Kluskowski, GHMC’s SVP, Group Creative Director – Copy, is an award-winning, multi-disciplined creative director who has brought fully integrated, breakthrough ideas to life for fast food restaurants, highly regulated pharmaceutical clients and everything in between.

Darryl has worked on the world’s most-recognized brands including AbbVie, AstraZeneca, Bayer, Burger King, Domino’s, Genentech, Janssen Pharmaceuticals, GSK, Hefty, Hostess, Pfizer, Popsicle, Progressive, Sanofi, Samsung, Takeda and Walgreens.

Along with being experienced in several therapeutic categories, Darryl has worked on multiple launches for oncology drugs. His branding experience includes work for UnitedHealthcare and other top healthcare companies.

Darryl is also the creator of the hit animated series, “Four Eyes!” that aired on Nickelodeon and Disney in over 70 countries.

Chetan is an experienced healthcare executive with expertise in Scientific and Brand Strategy development.​

Chetan joined GHMC in April 2022 after more than 20 years in strategy roles at agencies including Publicis’ Medicus Life Brands, GSW Advertising and inVentiv Health (now Syneos Health).​

Chetan brings to the table 15+ years of experience in activating brands that incite—from scientific branding strategy, positioning, and critical message development. Chetan’s experience focuses on targeted molecular therapeutics in a variety of therapeutic areas (autoimmune, inflammatory, neurologic, oncologic, and cardiologic disorders). His experience in dermatology ranges from supporting Dove (Glycerol QuatTM ), Humira (plaque psoriasis) and Recell (autologous therapy for burns). Leveraging his expertise in cellular and molecular pathways, Chetan contributes significant clinical insight and understanding of the mechanisms that underlie the pathobiology in these therapeutic areas. ​

Chetan completed his BA in biology from the University of Texas in Austin and subsequently earned his PhD in neuroscience from the Weill Graduate School of Medical Sciences of Cornell University/Sloan Kettering Institute (SKI), where his thesis work focused on mitochondrial dysfunction in neurodegenerative disorders. Chetan has published scientific articles in The Journal of Neuroscience, Biochemistry, and Human Molecular Genetics. ​

Ultimately, Chetan is a firm believer that in order to create brands that resonate with their audiences, that truly incite audiences, you must do more than create words—you must be able to transfer enthusiasm.

Modesto has more than 20 years of experience building, launching and working on integrated brand campaigns and experiences. He offers a uniquely fresh perspective having worked on national and global brands across fashion, entertainment, consumer, education, and health industries. In the healthcare space, Mo has worked across a wide variety of disease states and categories including cardiology, immunology, oncology, endocrinology and women’s health on brands such as Brilinta, Stelara, Kymriah, Phexxi and more. The work that excites him the most makes a positive impact and connects people and brands in authentic, memorable and inspiring ways.

Molly recently joined GHMC, bringing over 5 years experience in healthcare communications and a passion for applying behavioural science and psychology to health communications challenges.

Molly has experience delivering a range of communications programmes, centring on disease awareness, patient activation and influencer campaigns, branded campaigns, and internal and corporate communications, with a focus on generating attitudinal and behavioural change.

Molly has partnered with Global, European and local teams in a variety of therapeutic areas including dermatology, haematology, cardiology, urology, neurology and women’s health, with clients such as Sanofi, Novartis and Vifor. Notably, she spent the past 3 years supporting Galderma’s Global Rosacea Franchise, delivering and localizing a full spectrum of award-winning communications activities, including HCP branded, PR and patient activation campaigns.

Molly graduated from the London School of Economics with a Masters in social & cultural psychology and behavioural science, specializing in the use of psychology in health communications and applied behaviour change in health.